BAX vs. BMY
Compare and contrast key facts about Baxter International Inc. (BAX) and Bristol-Myers Squibb Company (BMY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BAX or BMY.
Correlation
The correlation between BAX and BMY is 0.36, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
BAX vs. BMY - Performance Comparison
Key characteristics
BAX:
-0.59
BMY:
0.60
BAX:
-0.73
BMY:
1.12
BAX:
0.91
BMY:
1.14
BAX:
-0.25
BMY:
0.37
BAX:
-0.86
BMY:
1.51
BAX:
19.19%
BMY:
11.61%
BAX:
27.83%
BMY:
29.24%
BAX:
-68.86%
BMY:
-70.62%
BAX:
-60.83%
BMY:
-24.36%
Fundamentals
BAX:
$15.74B
BMY:
$111.57B
BAX:
$0.25
BMY:
-$4.41
BAX:
2.09
BMY:
1.21
BAX:
$10.10B
BMY:
$48.30B
BAX:
$3.81B
BMY:
$32.20B
BAX:
$1.13B
BMY:
$3.16B
Returns By Period
In the year-to-date period, BAX achieves a 14.68% return, which is significantly higher than BMY's -0.27% return. Over the past 10 years, BAX has underperformed BMY with an annualized return of 0.40%, while BMY has yielded a comparatively higher 2.25% annualized return.
BAX
14.68%
6.23%
-7.18%
-18.53%
-16.84%
0.40%
BMY
-0.27%
-2.19%
19.78%
15.06%
0.36%
2.25%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
BAX vs. BMY — Risk-Adjusted Performance Rank
BAX
BMY
BAX vs. BMY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Baxter International Inc. (BAX) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BAX vs. BMY - Dividend Comparison
BAX's dividend yield for the trailing twelve months is around 3.11%, less than BMY's 4.34% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BAX Baxter International Inc. | 3.11% | 3.57% | 3.00% | 2.26% | 1.27% | 1.21% | 1.02% | 1.11% | 0.94% | 1.14% | 0.60% | 0.00% |
BMY Bristol-Myers Squibb Company | 4.34% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% |
Drawdowns
BAX vs. BMY - Drawdown Comparison
The maximum BAX drawdown since its inception was -68.86%, roughly equal to the maximum BMY drawdown of -70.62%. Use the drawdown chart below to compare losses from any high point for BAX and BMY. For additional features, visit the drawdowns tool.
Volatility
BAX vs. BMY - Volatility Comparison
Baxter International Inc. (BAX) has a higher volatility of 10.67% compared to Bristol-Myers Squibb Company (BMY) at 8.69%. This indicates that BAX's price experiences larger fluctuations and is considered to be riskier than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
BAX vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Baxter International Inc. and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities